Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

May 8, 2024

https://www.globenewswire.com/news-release/2024/05/08/2877574/36461/en/Voyager-Therapeutics-Presents-Data-for-Second-Generation-TRACER-Generated-Capsids-and-CNS-Gene-Therapy-Programs-Advancing-Toward-Clinical-Trials-at-the-ASGCT-27th-Annual-Meeting.html

– Translational potential of TRACER-derived AAV capsids demonstrated by data across multiple species (murine, porcine, multiple NHPs, human cells) and receptor binding –

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.